In this summary, “side effects” refer to those events that the study doctor thinks may
have been caused by the placebo. The side effects in this summary may be different to
those in the Informed Consent or other documents related to the study inhaler.
No children reported serious side effects in this study.
No children in age group 1 (5 to 7 years) reported non-serious side effects. In age group
2 (8 to 11 years), one child (less than 1%) out of 134 children had a non-serious side
effect of cough.
How has this study helped patients and researchers?
This study showed that the percentage of children who used the Ellipta inhaler
correctly and found it easy to use after four weeks was similar between the two age
groups.
Are there plans for further studies?
Other studies of the Ellipta inhaler in patients with asthma are ongoing.
Where can I find more information about this study?
Clinical studies have unique study numbers that are included in publications and other
information about the study. The unique study number associated with this study is
shown below with an internet link to the scientific summary and other information.
The scientific summary includes more details about the requirements for study
enrolment, the study visit schedule, results from other endpoints, and more detailed
information about adverse events.
Organisation Website Study Number
United States National
www.clinicaltrials.gov NCT034786571
Institutes of Health (NIH)
Your doctor can help you understand more about this study and the results. Speak to
your doctor about the treatment options available in your country. You should not
1https://clinicaltrials.gov/ct2/show/NCT03478657